Hybrid AI Model Helps Startups Revolutionize Real-Time ECG Monitoring for Early Heart Disease Detection.

Keywords: ECG classification, CNN-LSTM, Genetic Algorithm, AI in healthcare, real-time ECG monitoring, cardiovascular disease detection, healthtech startup, feature optimization

A new study from Bharathidasan University introduces a hybrid AI model that could transform real-time ECG monitoring, offering a startup-ready solution for early detection of cardiovascular diseases. Led by M. Durairaj and S. Selvakumari, the study combines Convolutional Neural Networks (CNNs), Long Short-Term Memory (LSTM) networks, and Genetic Algorithm-based feature optimization to deliver high accuracy without heavy computational costs.

The innovation addresses a key challenge in cardiovascular healthcare: detecting heart abnormalities quickly and accurately in real time. Many existing ECG classification systems are either too slow, too complex, or require large datasets, making them unsuitable for real-time clinical applications or portable medical devices. The new hybrid CNN-LSTM model solves this by efficiently reducing input data, accelerating training by about 30%, and maintaining top-tier performance in classification tasks.

In practice, this system can help startups develop wearable ECG devices or AI-powered monitoring platforms. For example, a wearable device using this AI could alert a user or medical professional immediately if an abnormal heart rhythm is detected, potentially preventing severe cardiac events.

The model was tested on the PTB-XL ECG dataset and achieved precision of 97.83%, accuracy of 98.12%, recall of 97.46%, specificity of 98.72%, and F1-score of 97.65%, outperforming traditional models like CNN, FSL, and ATCNN. Its ability to distinguish between normal and abnormal heart signals with minimal computational load makes it ideal for startups focusing on AI-assisted health tech solutions.

The novelty lies in integrating GA, SVM, and PCA feature optimization into a CNN-LSTM network, a combination not commonly seen in ECG analysis. This innovation could enable real-time clinical decision support systems, portable ECG monitoring tools, and AI-driven preventive healthcare solutions, addressing the growing global burden of cardiovascular disease.